Patient with diabetic retinopathy undergoing intravitreal Avastin injection.
Not Applicable
Completed
- Registration Number
- CTRI/2018/04/012956
- Lead Sponsor
- Giridhar Eye Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Patients with active fibrovascular proliferation due to proliferative diabetic retinopathy with or without tractional retinal detachment.
Exclusion Criteria
(a) patients below 18 years of age
(b) dense vitreous haemorrhage
(c) history of thromboembolic event or heart attack.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To document the changes at vitreo retinal interface by spectral domain optical coherence tomography, in patients with PDR after intravitreal Bevacizumab injection.Timepoint: 12 Months
- Secondary Outcome Measures
Name Time Method To determine any decrease in intra and post operative complication in patients with preoperative adjuvant bevacizumab injection and visual outcome in these patients.Timepoint: 12 Months